0 1 8 , ▁G SK ▁announced ▁that ▁Un ile ver ▁would ▁ac quire ▁the ▁Indian - list ed ▁Gla x o Smith K line ▁Cons umer ▁Health care ▁business ▁for ▁US $ 3 . 8 b ill ion ▁( £ 2 . 9 8 b ill ion ). ▁Un ile ver ▁will ▁pay ▁the ▁majority ▁of ▁the ▁deal ▁in ▁c ash , ▁with ▁the ▁remaining ▁being ▁paid ▁in ▁shares ▁in ▁its ▁O nd ian ▁operation , ▁H indust an ▁Un ile ver ▁Limited . ▁Upon ▁completion , ▁G SK ▁will ▁then ▁own ▁around ▁ 5 . 7 % ▁of ▁H indust an ▁Un ile ver ▁Limited , ▁s elling ▁those ▁shares ▁in ▁a ▁number ▁of ▁tran ches . ▁The ▁same ▁day , ▁the ▁company ▁also ▁announced ▁it ▁would ▁ac quire ▁on col ogy ▁special ist , ▁T es aro , ▁for ▁US $ 5 . 1 b ill ion . ▁The ▁deal ▁will ▁give ▁G SK ▁control ▁of ▁o var ian ▁cancer ▁treatment , ▁Ze j ula ▁- ▁a ▁member ▁of ▁the ▁class ▁of ▁poly ▁AD P ▁rib ose ▁polym er ase ▁( PAR P ) ▁in hib itors . ▁ ▁In ▁October ▁ 2 0 1 9 , ▁G SK ▁agreed ▁to ▁sell ▁its ▁ra b ies ▁v acc ine , ▁Rab A vert , ▁and ▁its ▁tick - bor ne ▁en ce phal itis ▁v acc ine , ▁En cep ur , ▁to ▁Bav arian ▁Nord ic ▁for ▁US $ 1 . 0 6 b ill ion ▁( € 9